Huaier Granule for Prevention of Recurrence and Metastasis of Stage II and III Non-small Cell Lung Cancer (NSCLC)

• Status: Terminated
• Trial end date: 2017-11-23

Summary

This study including two parts，one part is a randomized clinical trial design，another part is a registration study.

• Phase: N/A

Details

• Lead Sponsor: Qidong Gaitianli Medicines Co., Ltd